Sanjiv Patel, President and CEO at Relay Therapeutics, Inc. (RLAY), sold 122,844 shares at $2.97 ($365K) on 2025-04-23, disclosed to the SEC on 2025-04-24.
Open-market sale of $365k RLAY by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.97 | 18,653 | $55K | 15.2% |
| 2 | $2.97 | 18,653 | $55K | 15.2% |
| 3 | $2.97 | 42,769 | $127K | 34.8% |
| 4 | $2.97 | 42,769 | $127K | 34.8% |
| Total | $2.97 avg | 122,844 | $365K | 100% |
| Filing → |
| RLAY | SELL | 2026-08-18 | $980K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $944K | — | Filing → |
| RLAY | SELL | 2026-01-07 | $338K | — | Filing → |